| Literature DB >> 27513783 |
Nihal Efe1, Enver Altas, Muhammet Recai Mazlumoglu, Bulent Aktan, Harun Ucuncu, Suat Eren, Fatih Oner.
Abstract
Though the lymphangioma is a benign neoplasm, it may make an invasion to vital structures by progressively growing. For lymphangioma, which progressed in such a way, surgical treatment has high morbidity and recurrence risk. On these cases, OK-432 is a frequently used sclerotherapy agent. The authors report the result they obtained by the use of single-dose OK-432 on an inoperable pediatric cervical macrocystic lymphangioma case and also their experiences.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27513783 DOI： 10.1097/SCS.0000000000002983
Source DB: PubMed Journal: J Craniofac Surg ISSN： 1049-2275 Impact factor: 1.046